Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
27-30 April, 2026
Not Confirmed
Not Confirmed
27-29 April, 2026
Not Confirmed
Not Confirmed
27-30 April, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS





Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
27-30 April, 2026
Industry Trade Show
Not Confirmed
27-29 April, 2026
Industry Trade Show
Not Confirmed
27-30 April, 2026
Digital content

14 Apr 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/04/14/3273225/0/en/Praxis-Precision-Medicines-Announces-FDA-Acceptance-of-New-Drug-Application-for-Ulixacaltamide-HCl-in-Patients-with-Essential-Tremor.html

13 Apr 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/04/13/3272452/0/en/Praxis-to-Showcase-Essential3-the-First-Positive-Phase-3-Program-in-Essential-Tremor-at-AAN-2026.html

06 Apr 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/04/06/3268372/0/en/Praxis-Precision-Medicines-Announces-Positive-Results-from-the-EMBRAVE-Part-A-Trial-of-Elsunersen-in-Patients-with-SCN2A-Early-Onset-Developmental-and-Epileptic-Encephalopathy.html

02 Apr 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/04/02/3267813/0/en/Praxis-Precision-Medicines-Inc-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

30 Mar 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/03/30/3264996/0/en/Praxis-Precision-Medicines-Announces-FDA-Acceptance-and-Priority-Review-of-New-Drug-Application-for-Relutrigine-in-Patients-with-SCN2A-and-SCN8A-DEEs.html

04 Mar 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/03/04/3249717/0/en/Praxis-Precision-Medicines-Inc-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
ABOUT THIS PAGE